Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment

Richard Fleming, Lyndal Harborne, David T MacLaughlin, Daniel Ling, Jane Norman, Naveed Sattar, David B Seifer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment'. Together they form a unique fingerprint.

Medicine and Dentistry